Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Gregory G. Schwartz(University of Colorado Denver), Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Deepak L. Bhatt(Mount Sinai Hospital), Rafael Díaz(Estudios Clínicos Latinoamérica), Margus Viigimaa(Tallinn University of Technology), Nikolaus Marx(RWTH Aachen University), Patricio López‐Jaramillo(Universidad De Santander), Philip E. Aylward(Flinders Medical Centre), Peter Sinnaeve(Brigham and Women's Hospital), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Robert Pordy(Inserm), Željko Reiner, Shaun G. Goodman(University of Toronto), Vera Bittner(University of Alabama at Birmingham), Matthew T. Roe(Clinical Research Institute), Markku S. Nieminen(Cornell University), Robert A. Harrington(Clinical Research Institute), Megan Loy(Sanofi (United States)), Andreas M. Zeiher(Goethe University Frankfurt), Harvey D. White(University of Auckland), Nina Gotcheva, Renato D. Lópes(Duke University), Petr Ošťádal(Charles University), Michael Szarek(St. Michael's Hospital), Yong Huo(Sun Yat-sen University), Heinz Drexel(ESCP Business School), Garen Manvelian(Regeneron (United States)), Pierluigi Tricoci(Duke University), Corinne Hanotin(Sanofi (France)), Vakhtang Chumburidze, Mirza Dilić(Duke University), Jay M. Edelberg(Inserm), Angèle Moryusef(Inserm), William J. Sasiela(Inserm), Guillaume Lecorps(Sanofi (United States)), Juan-Carlos Prieto, Jean‐François Tamby(Medical University of South Carolina), Philippe Gabríel Steg(Mount Sinai Hospital), Ivan Pećin, J. Wouter Jukema(Leiden University Medical Center)
Cited by 39
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k